0
Aerie Pharmaceuticals Inc
- 501-1000 Employees
- Based in Durham, North Carolina
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, which is a once-daily eye drop that reduces intraocular pressure (IOP) in patients with glaucoma or ocular hypertension and is in Phase…More
Aerie Pharmaceuticals Inc
Most Recent Responsibility Report
MOST RECENT
Request Information
Aerie Pharmaceuticals Inc does not currently have any reports on ResponsibilityReports.co.uk. Click the button below to be notified when financial info becomes available.
Our service enables potential investors to review the most recent and archived Aerie Pharmaceuticals Inc Sustainability Report, Aerie Pharmaceuticals Inc Corporate Social Responsibility Report, Aerie Pharmaceuticals Inc CSR Report, Aerie Pharmaceuticals Inc Corporate Responsibility, Aerie Pharmaceuticals Inc CR Report, Aerie Pharmaceuticals Inc Citizenship Report, Aerie Pharmaceuticals Inc ESG Report, and Aerie Pharmaceuticals Inc Environmental Report online.